
“Can someone have a bone marrow transplant after 60?” rarely has a useful answer in the form of one age limit. The decision involves the disease, earlier treatment, organ function and everyday independence. An enquiry to a centre in Turkey should therefore ask for an individual assessment rather than assume acceptance or rejection from the date of birth.
NMDP emphasises that chronological age alone should not determine eligibility for allogeneic transplantation. Physical function and other health conditions also matter. Two people of the same age can have different clinical circumstances, so an age rule cannot provide a meaningful comparison of their proposals.
This does not mean transplantation is appropriate for every older adult. Ask the physician to identify the clinical aim, relevant alternatives and the information still required for a decision. Assessment may lead to a recommendation for a different approach; it is not a commitment to perform a transplant.
Alongside the medical records, prepare a brief account of mobility, routine activities, eating and the help needed at home. Explain whether this changed after the latest treatment or hospital stay. The description does not replace a clinician’s functional assessment, but it helps make the initial conversation more specific.
If a relative provides support, say what that involves. “Doing well” can conceal important limitations, while “very weak” may describe a recent change needing its own explanation. Separate the person’s usual abilities from changes in recent weeks rather than trying to decide suitability yourselves.
One history concerns the blood condition: diagnosis, treatment, response and the haematologist’s current question. The other concerns general health: other diagnoses, significant operations, complications, medicines and allergies. Send investigations and specialist letters already available. The centre should clarify what is sufficiently current and whether anything needs repeating.
Identify recent infections, admissions and prescribed treatment separately. Do not stop medicines for an investigation without instructions. If a document is still pending, say so; a missing result should never be presented as normal because the report has not arrived.
If preparation for transplant is discussed, ask the team to explain its choice and limitations. Reduced intensity should not be self-selected as a “safe option for my age”. Similarly, a published study of older recipients cannot predict your result: study groups differ in disease status and other clinical details.
Discuss caregiver support and follow-up after returning home: who can be there, which local doctor will receive the discharge summary and how arrangements would adapt if recovery took longer than hoped. The support described in the referral must be realistic, rather than entered simply to speed up a travel booking. Medical readiness for the journey belongs to the treating clinicians.
Our article on pre-transplant checks covers the broader assessment process, while the bone marrow transplant page provides related enquiry context. Use the Medicina Turkey form to clarify arrangements for submitting existing records. Acute deterioration requires timely care where you are, rather than waiting for a decision about treatment abroad.
Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.
Choose whether Google Analytics and Google Ads may use optional cookies and measurement data. This panel controls Google measurement only; other site tools are not managed here. If you decline, Google may receive limited signals without cookies.
Your choice is remembered for up to 180 days and can be changed at any time. Personalised advertising stays off.